Marion McCourt sold $984K of Regeneron Pharmaceuticals (REGN)

Executed Oct 30, disclosed Nov 3, 4 days later.

Value, as filed

$984K

1,132 sh × $869.43

Executed

Oct 30

the trade date, as filed

Disclosed

Nov 3

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Marion McCourt EVP Commercial profile →

Marion McCourt (EVP Commercial) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $984K of REGN (1,132 sh × $869.43, as filed), executed Oct 30.

The name

REGN

Regeneron Pharmaceuticals, Inc. REGN · Healthcare · 35 filings in 24 months ticker →

Healthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Marion McCourt in REGN

REGNSALE Regeneron Pharmaceuticals, Inc. $845K
1,000 sh × $844.61
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET